TESAMORELIN 10 mg LOBO Peptides research vial
Research record / sandbox checkout

Tesamorelin 10mg

Tesamorelin 10 mg is a stabilized analogue of the 44-residue growth-hormone-releasing hormone sequence, cataloged as a laboratory reference material. The entry preserves the stated amount while leaving lot composition and physical format unresolved. For research use only (RUO); not for human or veterinary use.

Sandbox test price $149.97
Research-only sandbox Not for human consumption. No charge. No shipping. No fulfillment.

Out of stock

Tesamorelin Product Description

Tesamorelin is described in the literature as a synthetic analogue of the full 44-residue growth-hormone-releasing hormone sequence. That identity places it within GHRH-receptor research rather than the separate class of growth-hormone secretagogue receptor agonists. The supplied catalog record states 10 mg, but it does not establish salt form, excipients, physical presentation, or analytical characteristics of a specific lot. Those attributes remain documentation questions rather than facts that can be inferred from the name.

For experimental design, the most important boundary is molecular identity. Tesamorelin should not be collapsed into GHRH(1-29), sermorelin, CJC-1295 with DAC, no-DAC modified GRF, or ipamorelin. Each has a different sequence, modification pattern, or receptor-pharmacology rationale. A study that names one of those adjacent materials cannot automatically substantiate a tesamorelin experiment, and a catalog amount alone does not demonstrate equivalence to material used in a publication.

The cited controlled studies examined tesamorelin in defined adult participant groups using imaging, endocrine biomarkers, and metabolic laboratory measures. They are useful for understanding which variables investigators selected and how observations were bounded by protocol. They do not establish intended use, performance, safety, or composition for this research listing. Any comparison should preserve population, assay timing, analytical method, and study design rather than translating participant-level observations into a catalog promise.

This entry is therefore framed as a research-use-only identity record. Suitable discussion is limited to receptor biology, assay selection, biomarker methodology, and comparison of experimental systems. Lot-specific identity, content, purity, sterility, endotoxin status, and stability cannot be supplied from the cited papers or the label amount and require separate documentation. The catalog identity and the literature identity are recorded as separate evidence layers so that future documentation can resolve open attributes without rewriting the scientific history or overstating what the current source set demonstrates within defined research boundaries.

Research Material Profile

Literature identity: Tesamorelin, a synthetic analogue of the 44-residue growth-hormone-releasing hormone sequence
Research class: GHRH-receptor research analogue
Labeled amount: 10 mg
Pack format: One catalog unit labeled 10 mg; vial or other physical container format is not confirmed by the supplied record
Unresolved attributes: Salt or counterion, excipients, physical state, container details, lot identity, and analytical results are unresolved
Identity boundary: It is not interchangeable with shorter GHRH fragments, CJC-1295 variants, or secretagogue-receptor agonists such as ipamorelin.